title: Integration of buprenorphine for substance-abuse treatment by HIV care providers.
authors.affiliation: The Yale School of Medicine, New Haven, CT 06510-2483, USA. gerald.friedland@yale.edu
authors.forename: Gerald
authors.initials: G
authors.lastname: Friedland
authors.forename: David
authors.initials: D
authors.lastname: Vlahov
mesh_terms: D002047:Buprenorphine / Q000627:therapeutic use*; D000069479:Buprenorphine, Naloxone Drug Combination; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D058850:Opiate Substitution Treatment; D009293:Opioid-Related Disorders / Q000150:complications / Q000188:drug therapy*
chemical_list: D000069479:Buprenorphine, Naloxone Drug Combination; D009292:Narcotic Antagonists; D009270:Naloxone; D002047:Buprenorphine